Pure Bioscience (PURE) President reports insider stock and option positions
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Pure Bioscience, Inc. officer Jeffrey Scott Kitchell, who serves as President and Corporate Secretary, reported his beneficial ownership of company securities as of 11/17/2025. He directly holds 12,998 shares of Pure Bioscience common stock. In addition, he holds several stock option awards giving him the right to buy common shares at exercise prices ranging from $0.07 to $0.79 per share, with expiration dates extending through 2034. Earlier option grants from 2020 through 2024 are already fully vested, while an option granted on September 23, 2025 for 300,000 shares is scheduled to vest in four equal installments on December 23, 2025, March 23, 2026, June 23, 2026, and September 23, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Kitchell Jeffrey Scott
Role
President, Corporate Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 45,000 shares (Direct);
Common Stock — 12,998 shares (Direct)
Footnotes (1)
- The option was granted on January 29, 2020 and became fully vested on January 29, 2021. The option was granted on May 15, 2020 and became fully vested on May 15, 2021. The option was granted on June 18, 2021 and became fully vested on June 18, 2022. The option was granted on September 30, 2022 and became fully vested on September 30, 2023. The option was granted on August 1, 2023 and became fully vested on August 1, 2024. The option was granted on August 20, 2024 and became fully vested on August 20, 2025. The option was granted on September 23, 2025. The option shares shall vest and become exercisable in four equal installments on December 23, 2025, March 23, 2026, June 23, 2026, and September 23, 2026.
